HSBC TUR.WAR.OP.END. TRL/ DE000HS3FFK1 /
12/11/2024 21:37:10 | Diferencia+0.340 | Bid21:59:53 | Ask- | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
5.490EUR | +6.60% | 5.460 Volumen de oferta: 30,000 |
- Tamaño/ Volumen/ Formato de Ask: - |
DaVita Inc | 101.0934 USD | 31/12/2078 | Call |
GlobeNewswire
24/06
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
18/06
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
26/04
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
17/11/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
15/08/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
21/03/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
07/03/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
10/02/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
07/10/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
01/10/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página